Ask Dr. Frey: Your Questions Answered, Vol. 3
Dr. Kevin Frey is CBDistillery’s Medical Advisor and, as an internal medicine expert, sees significant potential benefits in the use of CBD.
He’s part of our mission to increase CBD education, so he’s offered to answer questions you may have about cannabinoid wellness!
Recently, Dr. Frey joined us on Instagram Live to answer some of your CBD curiosities. Check out his responses below.
Update, Oct. 2023: This piece was written while Dr. Frey was serving as CBDistillery’s Medical Advisor. He is no longer affiliated with the company.
Q. Many of the questions we received were regarding specific medical conditions. What advice do you have for those who have diagnosed ailments and want to know whether CBD can help?
A. Consult your primary care physician for personalized guidance on using CBD for specific medical conditions.
Q. What is the best CBD product for stress?
A. The best CBD product for stress is whatever works best for you. It's best to experiment with different formulations. In saying that, participants in a 2022 CBDistillery® study reported that using our 15mg CBG + 15mg CBD tincture resulted in an improved quality of life and better management of mild or temporary anxiety. I would suggest that capsules and/or gummies are most effective and long lasting.
Q. What studies have been performed on the long-term use of CBD in humans?
A. There has been some research on the long-term use of CBD in humans, but more research is needed.
Some studies have shown that CBD is generally safe and can be effective in treating a variety of conditions, such as anxiety, pain, and insomnia. However, more research is needed to confirm these findings and to assess the long-term safety and efficacy of CBD. Here are some of the limitations of the research on CBD:
Small sample sizes: Many of the studies on CBD have been small, with only a few hundred or even a few dozen participants. This makes it difficult to generalize the results to a wider population.
Short duration: Many of the studies on CBD have been short-term, lasting only a few weeks or months. This makes it difficult to assess the long-term safety and efficacy of CBD.
Lack of placebo control groups: Some of the studies on CBD have not included a placebo control group. This makes it difficult to determine whether the effects of CBD are due to the CBD itself or to other factors, such as the placebo effect.
Despite these limitations, the research on CBD is promising. More research is needed to confirm the findings of the existing studies and to assess the long-term safety and efficacy of CBD.